Blagosklonny MV - Search Results

1

p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation.

Broude EV, Swift ME, Vivo C, Chang BD, Davis BM, Kalurupalle S, Blagosklonny MV, Roninson IB. Broude EV, et al. Among authors: blagosklonny mv. Oncogene. 2007 Oct 18;26(48):6954-8. doi: 10.1038/sj.onc.1210516. Epub 2007 May 7. Oncogene. 2007. PMID: 17486059

2

p21 (CDKN1A) is a negative regulator of p53 stability.

Broude EV, Demidenko ZN, Vivo C, Swift ME, Davis BM, Blagosklonny MV, Roninson IB. Broude EV, et al. Among authors: blagosklonny mv. Cell Cycle. 2007 Jun 15;6(12):1468-71. Epub 2007 Apr 12. Cell Cycle. 2007. PMID: 17585201

3

Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis.

Demidenko ZN, Kalurupalle S, Hanko C, Lim CU, Broude E, Blagosklonny MV. Demidenko ZN, et al. Among authors: blagosklonny mv. Oncogene. 2008 Jul 24;27(32):4402-10. doi: 10.1038/onc.2008.82. Epub 2008 May 12. Oncogene. 2008. PMID: 18469851

4

Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection.

Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV, Blagosklonny MV. Demidenko ZN, et al. Among authors: blagosklonny mv. Cell Death Differ. 2006 Sep;13(9):1434-41. doi: 10.1038/sj.cdd.4401812. Epub 2005 Nov 25. Cell Death Differ. 2006. PMID: 16311509

5

Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.

Giannakakou P, Robey R, Fojo T, Blagosklonny MV. Giannakakou P, et al. Among authors: blagosklonny mv. Oncogene. 2001 Jun 28;20(29):3806-13. doi: 10.1038/sj.onc.1204487. Oncogene. 2001. PMID: 11439344

6

Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpoint.

Kim JS, Pirnia F, Choi YH, Nguyen PM, Knepper B, Tsokos M, Schulte TW, Birrer MJ, Blagosklonny MV, Schaefer O, Mushinski JF, Trepel JB. Kim JS, et al. Among authors: blagosklonny mv. Oncogene. 2000 Dec 7;19(52):6082-90. doi: 10.1038/sj.onc.1204008. Oncogene. 2000. PMID: 11146561

7

Loss of function and p53 protein stabilization.

Blagosklonny MV. Blagosklonny MV. Oncogene. 1997 Oct 16;15(16):1889-93. doi: 10.1038/sj.onc.1201374. Oncogene. 1997. PMID: 9365234 Review.

8

Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer.

Giannakakou P, Poy G, Zhan Z, Knutsen T, Blagosklonny MV, Fojo T. Giannakakou P, et al. Among authors: blagosklonny mv. Oncogene. 2000 Jun 22;19(27):3078-85. doi: 10.1038/sj.onc.1203642. Oncogene. 2000. PMID: 10871860

9

Accumulation of hypoxia-inducible factor-1alpha is limited by transcription-dependent depletion.

Demidenko ZN, Rapisarda A, Garayoa M, Giannakakou P, Melillo G, Blagosklonny MV. Demidenko ZN, et al. Among authors: blagosklonny mv. Oncogene. 2005 Jul 14;24(30):4829-38. doi: 10.1038/sj.onc.1208636. Oncogene. 2005. PMID: 15897903

10

Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs.

Blagosklonny MV. Blagosklonny MV. Oncogene. 2002 Sep 12;21(41):6249-54. doi: 10.1038/sj.onc.1205793. Oncogene. 2002. PMID: 12214265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters